Hormonal therapy of gynecologic malignancy.
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D002278:Carcinoma in Situ / Q000188:drug therapy*; D004116:Dimethisterone / Q000008:administration & dosage / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000627:therapeutic use*; D005040:Ethynodiol Diacetate / Q000008:administration & dosage / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006908:Hydroxyprogesterones / Q000008:administration & dosage / Q000627:therapeutic use; D007273:Injections, Intramuscular; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000627:therapeutic use; D009362:Neoplasm Metastasis; D009640:Norethindrone / Q000008:administration & dosage / Q000627:therapeutic use; D009650:Norpregnanes / Q000008:administration & dosage / Q000627:therapeutic use; D011374:Progesterone / Q000008:administration & dosage / Q000627:therapeutic use*; D011388:Prolactin / Q000502:physiology; D012008:Recurrence; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000601:surgery; D014599:Uterus
D000305:Adrenal Cortex Hormones; D004967:Estrogens; D006908:Hydroxyprogesterones; D009650:Norpregnanes; D011374:Progesterone; D005040:Ethynodiol Diacetate; D011388:Prolactin; D008525:Medroxyprogesterone; D004116:Dimethisterone; D009640:Norethindrone